TRY MEDICS ApS Financials, key figures and credit report
Gross profit 4 540.8 kDKK FY 2025 +54.4% vs 2024
EBIT 2 795.9 kDKK FY 2025 +42.2% vs 2024
Net debt -8 750.5 kDKK FY 2025 -38.6% vs 2024
Quick ratio 23.1 FY 2025 +13.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 850.45 | 3 168.92 | 1 136.16 | 2 940.17 | 4 540.85 |
| Employee benefit expenses | - 603.77 | - 609.74 | - 615.33 | - 973.69 | -1 744.91 |
| EBIT | 246.68 | 2 559.18 | 520.83 | 1 966.49 | 2 795.93 |
| Other financial income | 20.92 | 41.26 | 74.25 | 115.94 | 32.08 |
| Other financial expenses | -25.10 | -41.52 | -2.94 | ||
| Pre-tax profit | 267.59 | 2 575.34 | 595.08 | 2 040.91 | 2 825.07 |
| Income taxes | -58.93 | - 562.37 | - 130.94 | - 450.07 | - 621.60 |
| Net earnings | 208.67 | 2 012.97 | 464.14 | 1 590.83 | 2 203.48 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | 12.52 | 12.52 | 12.52 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 514.62 | 533.60 | 26.20 | 671.57 | |
| Prepayments and accrued income | 164.16 | 63.97 | 1 210.45 | ||
| Current other receivables | 237.77 | 105.89 | 141.00 | 186.79 | 337.31 |
| Short term receivables total | 752.39 | 639.49 | 331.36 | 250.75 | 2 219.33 |
| Cash and bank deposits | 3 564.98 | 5 618.06 | 4 954.34 | 6 421.31 | 8 751.92 |
| Cash and cash equivalents | 3 564.98 | 5 618.06 | 4 954.34 | 6 421.31 | 8 751.92 |
| Balance sheet total (assets) | 4 317.37 | 6 257.55 | 5 298.22 | 6 684.58 | 10 983.76 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 1 500.00 | 460.00 | 1 500.00 | 1 500.00 | |
| Retained earnings | 233.09 | -1 058.24 | 494.73 | - 541.13 | - 450.29 |
| Profit of the financial year | 208.67 | 2 012.97 | 464.14 | 1 590.83 | 2 203.48 |
| Shareholders equity total | 491.76 | 2 504.73 | 1 468.87 | 2 599.71 | 3 303.18 |
| Provisions | 0.00 | 266.30 | |||
| Non-current other liabilities | 582.83 | ||||
| Non-current deferred tax liabilities | 451.47 | ||||
| Non-current liabilities total | 582.83 | 451.47 | |||
| Current loans from credit institutions | 112.87 | ||||
| Advances received | 3 067.91 | 2 548.23 | 3 627.33 | 3 413.69 | 6 939.33 |
| Current trade creditors | 36.20 | 36.20 | 36.20 | 81.30 | 41.38 |
| Current owed to participating | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
| Current owed to group member | 104.74 | ||||
| Short-term deferred tax liabilities | 1.57 | 562.37 | 130.94 | 450.07 | 355.30 |
| Other non-interest bearing current liabilities | 135.70 | 40.28 | 33.48 | 33.68 | 76.89 |
| Current liabilities total | 3 242.78 | 3 301.35 | 3 829.34 | 4 084.88 | 7 414.28 |
| Balance sheet total (liabilities) | 4 317.37 | 6 257.55 | 5 298.22 | 6 684.58 | 10 983.76 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated